Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by University Hospital of Liege
Sponsor:
Collaborators:
AZ Sint-Jan AV
Ziekenhuis Netwerk Antwerpen (ZNA)
Jules Bordet Institute
University Hospital, Gasthuisberg
AZ-VUB
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
University Hospital, Antwerp
Cliniques Universitaires de Mont-Godinne
Hospital de Jolimont
University Hospital, Ghent
AZ Delta Roeselare-Menen
Information provided by (Responsible Party):
Yves Beguin, University Hospital of Liege
ClinicalTrials.gov Identifier:
NCT01428973
First received: September 1, 2011
Last updated: November 8, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2020
  Estimated Primary Completion Date: September 2020 (Final data collection date for primary outcome measure)